Survival advantage with immune checkpoint inhibitor for advanced kidney cancer patients

Sunday, September 27, 2015 - 20:00 in Health & Medicine

For the first time, an immune checkpoint inhibitor has been proven to increase survival among patients with advanced renal cell carcinoma, a patient population for whom treatment options are currently limited.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net